IOVANCE BIOTHERAPEUTICS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

IOVANCE BIOTHERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $163.08 million for the year ending 2025.

  • IOVANCE BIOTHERAPEUTICS, INC. showed an increase of +41.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from IOVANCE BIOTHERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2025: $163.08 million | Fiscal year 2024: $115.69 million | Fiscal year 2023: $114.89 million | Fiscal year 2022: $231.73 million | Fiscal year 2021: $78.23 million | Fiscal year 2020: $67.33 million | Fiscal year 2019: $13.97 million | Fiscal year 2018: $82.15 million | Fiscal year 2017: $145.37 million | Fiscal year 2016: $106.72 million | Fiscal year 2015: $33.59 million | Fiscal year 2014: $44.91 million | Fiscal year 2013: $19.67 million | Fiscal year 2012: $0.00 | Fiscal year 2011: $510.2 thousand | Fiscal year 2010: $1.29 million | Fiscal year 2009: $8.3 thousand | Fiscal year 2008: $2.9 thousand | Fiscal year 2007: $0.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: